SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-410532
Filing Date
2014-11-13
Accepted
2014-11-13 10:28:51
Documents
12
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d799265d10q.htm 10-Q 261952
2 EX-10.1 d799265dex101.htm EX-10.1 16460
3 EX-10.2 d799265dex102.htm EX-10.2 34939
4 EX-31.1 d799265dex311.htm EX-31.1 6697
5 EX-31.2 d799265dex312.htm EX-31.2 6703
6 EX-32.1 d799265dex321.htm EX-32.1 5307
  Complete submission text file 0001193125-14-410532.txt   2523662

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT oxgn-20140930.xml EX-101.INS 278240
8 XBRL TAXONOMY EXTENSION SCHEMA oxgn-20140930.xsd EX-101.SCH 28514
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oxgn-20140930_cal.xml EX-101.CAL 32124
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oxgn-20140930_def.xml EX-101.DEF 63529
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE oxgn-20140930_lab.xml EX-101.LAB 234028
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oxgn-20140930_pre.xml EX-101.PRE 148837
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 141216706
SIC: 2836 Biological Products, (No Diagnostic Substances)